Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Safety board clears TxCell to restart Ovasave study that was halted last year

TxCell has been cleared to restart a Phase IIb trial of its candidate Crohn’s disease cell therapy by European regulators.

US FDA warns CordenPharma about Italian antibiotic API and cancer injectables plant

The US FDA was warned CordenPharma about manufacturing operations at a plant in Italy that was approved to make injectable cancer drugs last year.

Biocon granted permission for $158m expansion at Indian biomanufacturing site

Indian drugmaker Biocon has been given the go-ahead to expand a biopharmaceutical manufacturing facility in Bangalore.

Inflectra-maker Celltrion to expand biosimilar capacity by 170,000L

Celltrion will invest $275m at its biosimilar production site in Korea to ramp up capacity from 140,000L to 310,000L by 2021.

Xellia starts work on testing lab at Hungary API plant citing growing demand

Xellia Pharmaceuticals has started building a stability and release-testing unit at its API facility in Budapest, Hungary that is designed to support increased output.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...